Pd - Parkinson's Disease Clinical Trials
2 recruiting trials for Pd - Parkinson's Disease. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Pd - Parkinson's Disease clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University of California, San Francisco (1), Tel-Aviv Sourasky Medical Center (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Medtronic Percept Deep Brain Stimulation (cDBS) (device, 1 trial), followed by Medtronic Percept Deep Brain Stimulation (daytime aDBS), Medtronic Percept Deep Brain Stimulation (nighttime aDBS).
Track Pd - Parkinson's Disease trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease
The purpose of this study is to test a new way to treat Parkinson's disease (PD). Subjects will be implanted with deep brain stimulator (DBS) devices and electrodes placed under...
Freezing of Gait - Clinical Outcomes Assessment
To develop a reliable and accurate clinician-reported outcome (ClinRO) measure (against a new and precise definition) and patient reported outcome (PRO) for use by clinicians and...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Pd - Parkinson's Disease, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Pd - Parkinson's Disease, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Pd - Parkinson's Disease, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.